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Abstract
Background Studies have shown that obesity is associated
with venous flow disturbances that lead to changes of the
biomechanical forces on the venous wall known as shear
stress. We hypothesized that weight loss due to bariatric
surgery affects the venous hemodynamics and biomechanical
forces on the venous wall. The aim of this study was to
evaluate the effects of laparoscopic sleeve gastrectomy
(LSG) on the wall shear stress (WSS) and the venous hemo-
dynamics of the femoral vein.
Methods We studied ten morbidly obese patients who
underwent LSG. We investigated venous hemodynamics be-
fore, 6 and 12 months after LSG. The femoral vein diameter,
cross-sectional area, peak (PeakV) and maximum (TAmax)
velocities, WSS, and shear rate (SR) were assessed.
Results PeakV and TAmax were significantly lower in the
obese patients compared with the control group. WSS and
SR were significantly lower in the obese patients compared
with the control subjects. Venous hemodynamic parameters
increased in the postoperative period at baseline compared
with 12 months after surgery: PeakV increased from 17.53
(14.25–20.01)cm/s to 25.1 (20.9–30.1)cm/s (P=0.04) and the
TAmax from 12.97 (11.51–14.6)cm/s to 18.46 (13.24–24.13)
cm/s (P=0.057). WSS significantly increased from 0.21
(0.19–0.23)Pa at baseline to 0.31 (0.23–0.52)Pa 12 months
after surgery (P=0.031). SR also significantly increased from
47.92 (43.93–58.55)s−1 at baseline to 76.81 (54.04–109.5)s−1
12 months after surgery (P=0.02).
Conclusions This study showed that weight loss due to LSG
significantly changes the biomechanical forces on the femoral
vein generated by blood flow.
Keywords Obesity . Venous wall shear stress . Sleeve
gastrectomy
Introduction
The results of recent studies suggest that obesity is associated
with an increased risk of venous disease, but the main mech-
anisms leading to the development of chronic venous disease
are not clearly defined. The previous studies have shown that
obesity is associated with an increase in both intraabdominal
and iliofemoral venous pressure [1], greater foot venous pres-
sure, and deep venous reflux [2]. Recent studies also suggest
that inflammatory processes play an important role in deter-
mining vein wall damage, especially in the venous valve in
patients with venous disease [3, 4].
These studies confirmed that wall shear stress is a product
of the whole blood viscosity and the shear rate effect of
endothelium function [5], the migration of leukocytes, coag-
ulation, and inflammatory reactions [6]. These studies also
suggest that shear stress may affect factors determining the
risk of venous thrombosis and progressive grades of chronic
venous insufficiency. Other authors have recently reported
that obesity is associated with alteration of shear stress and
venous hemodynamics in the lower limbs [7]. The present
study has shown significantly lower shear stress at the femoral
vein in the obese individuals compared with the control sub-
jects. It is known that low shear stress and turbulent or re-
versed blood flow lead to inflammatory reactions, which has
recently been recognized as an important etiologic factor of
venous disease [8]. To our knowledge, the effects of weight
loss due to bariatric surgery on wall shear stress of the femoral
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vein have not yet been established. The aim of this study was
to evaluate the effects of weight loss due to sleeve gastrectomy
on the wall shear stress of the femoral vein in morbid obesity.
Material and Methods
The study included ten morbidly obese patients without signs
and symptoms of chronic venous disease who underwent
laparoscopic sleeve gastrectomy. Patients with varicosities,
lower extremity edema, pigmentation or lipodermatosclerosis,
and healed or active venous ulcers were excluded. Additional
factors used as exclusion criteria included the following:
smoking, diabetes mellitus, uncontrolled hypertension, heart
disease, history of leg vein thrombosis, history of antithrom-
botic and/or estrogen and/or contraceptive therapy, clinical
signs of arterial disease, prior limb surgery or sclerotherapy,
and lack of patient consent to participate. The exclusion
criteria related to using estrogen, contraceptive therapy, anti-
coagulants, and antiplatelet agents were applied to a period of
3 months before the study date. Ultrasound examinations
excluded patients with evidence of a valve dysfunction or
thrombosis. Anthropometric, hemodynamic, and biomechan-
ical parameters before the operation were compared to those
of the control group.
Patients enrolled into the study underwent laparoscopic
sleeve gastrectomy (LSG). In this study, LSG was performed
according to the commonly used technique [9, 10]. Greater
curvature vessels were divided using the LigaSure device
(Covidien™, USA). A longitudinal resection of the stomach
was created using a linear cutting stapler (Echelon 60 Flex
Endopath®, Ethicon Endosurgery, USA) beginning from the
point 5 to 6 cm proximal to the pylorus and continuing to the
angle of His, tightly abutting the bougie (a 36-French) that
was placed transorally into the pyloric channel along the lesser
curvature.
Patients were followed for 1 year following the procedure.
The patients were weighed, examined, including a Doppler
ultrasound exam, and interviewed by the surgeon and blood
was drawn for whole blood viscosity measurements, preoper-
atively and 6 and 12 months after the operation.
The control group consisted of 18 nonobese people without
arterial hypertension, diabetes mellitus, or any of the other
above-listed features. This group was recruited from volun-
teers from the medical staff. The study protocol was approved
by the ethical committee of the Medical University of Silesia,
and all participants provided written consent for participation
in the study.
Blood samples were collected from the cubital vein with a
syringe for a biochemical examination and anticoagulated
with K3EDTA (milligrams per milliliter) for rheological tests.
The rheological tests were performed at a stable temperature
of 37 °Cwithin 2 h after the blood was collected.Whole blood
viscosity measurements were performed using a Brookfield
DV-II+ (Wells-Brookfield, USA) cone-plate viscometer at
shear rates of 250 s−1.
Duplex ultrasound assessments of venous flow were per-
formed with a LOGIQe (GE Healthcare, Wipro, India) scan-
ner using an 8-MHz linear array probe. Ultrasound examina-
tions were performed in a standardized supine positionwith an
upper body elevation of 10° during normal quiet respiration.
Venous flow dynamics and the vein diameter were measured
at the common femoral vein within 1–1.5 cm proximal to the
entrance of the greater saphenous vein. The flow velocity
profile was studied in a longitudinal section of the common
femoral vein, and a spectral Doppler image was obtained in 7–
10 s from the center of the vessel. The vein’s diameter was
measured by identifying a transverse scan on B-mode imaging
of the intimal-luminal interfaces. The flow velocity profile
was studied in a longitudinal section of the common femoral
vein, obtaining a spectral Doppler signal. The femoral venous
flow velocity was measured if the angle between the ultra-
sound beam and the longitudinal vessel axis was 60° or less.
Dedicated software provided enveloping of the spectral wave-
forms with automated estimation of the Peak velocity (PeakV)
and time-averaged maximum velocity (TAmax). After 1 min
for stabilization, PeakV, TAmax, and vascular diameter were
obtained. Three measurements were performed for each of the
evaluated parameters at 1 min intervals, and the mean value of
each measurement was used for the final calculations. Ultra-
sound settings, such as gain, contrast, and rejection, were
optimized during the initial evaluation and held constant
thereafter. The cross-sectional area of the femoral vein was
calculated from the formula π×D2/4, where D denotes diam-
eter. Shear rate was estimated from the measured blood flow
velocity and the diameter of the femoral vein according to the
equation: γ=4×Vmax/D [11], where Vmax denotes maximal
velocity, which in our study corresponds to TAmax.We applied
the equation that is used for estimating the flow in the arteri-
ole. The venous wall shear stress (τ) was calculated from the
blood viscosity (η) and the shear rate (γ) assuming Newton’s
law. Wall shear stress was calculated from the whole blood
viscosity at shear rates of 250 s−1. At this shear rate, blood
may be regarded as a Newtonian fluid [12]. Validation and
reproducibility of this method for estimating shear stress have
been described previously [13].
Statistical Analysis
The continuous variables are presented as the median and the
interquartile range. The categorical variables are presented as
the absolute numbers and percentages. Statistical comparisons
were achieved by using the Mann–Whitney U test for inde-
pendent groups: morbidly obese vs. control groups prior to
surgery and morbidly obese vs. control groups 12 months
after surgery. Fisher’s exact test was performed to compare
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differences for categorical data. Differences in each variable at
the three time points (before surgery and 6 and 12months after
surgery) were calculated by the Friedman ANOVA test
followed by Scheffe’s post hoc test. A P value <0.05 was
considered significant. The statistical analysis was performed
using Statistica 10 (StatSoft Inc.).
Results
The baseline characteristics of the study population and their
comparisons to the control group are presented in Table 1. The
gender distribution and ages were similar in the obese and
control groups. Anthropometric parameters were respectively
higher in the obese subjects. The femoral vein diameter and
the cross-sectional area were significantly higher in the obese
group than in the control group (Table 1). PeakV and TAmax
were significantly lower in the obese patients compared with
the control group (Table 1). The shear rate and the wall shear
stress were significantly lower in the morbidly obese group
than in the control group. Anthropometric parameters changed
at each time point after surgery. The median weight and BMI
significantly decreased at each time point after surgery com-
pared to the preoperative value (Table 2). WHR, diameter, and
cross-sectional area of the vein significantly decreased
12 months after the operation compared to the baseline value
(Table 2). Venous hemodynamic parameters increased post-
operatively at each time point. Significant differences were
observed for PeakV, which elevated from 17.53 (14.25–
20.01)cm/s at baseline compared to 25.1 (20.9–30.1)cm/s
12 months after surgery (P=0.040, Table 2); TAmax tended
to be higher at baseline compared to 12 months after surgery
from 12.97 (11.51–14.6)cm/s to 18.46 (13.24–24.13)cm/s
(P=0.057, Table 2). The same increasing trend was observed
for shear rate and wall shear stress. Wall shear stress signifi-
cantly increased from 0.21 (0.19–0.23)Pa at baseline to 0.31
(0.23–0.52)Pa 12 months after surgery (P=0.031; Table 2 and
Fig. 1). Shear rate also significantly increased from 47.92
(43.93–58.55)s−1 at baseline to 76.81 (54.04–109.5)s−1
12 months after surgery (P=0.020; Table 2 and Fig. 2). There
were no differences in the venous hemodynamics of the lower
limbs between the obese and control participants 12 months
after surgery (Table 3).
Discussion
Many obese patients have clinical signs of severe venous
disease, including venous stasis ulcers and changes in the skin
and subcutaneous tissue, such as pigmentation or
lipodermatosclerosis related to venous stasis [14]. Epidemio-
logical studies have demonstrated that obesity is associated
with an increased risk of venous disease [15, 16], but the
primary mechanisms leading to the development of chronic
venous disease are not clearly defined. van Rij et al. found a
higher incidence of severe venous disease in obese persons,
according to clinical-etiologic-anatomic-pathophysiologic
grading and greater foot venous pressure and reflux measures,
such as the venous filling index and the venous filling time
[2]. Another study demonstrated that obesity is associated
with increased intra-abdominal and iliofemoral venous pres-
sure that may contribute to the development of venous insuf-
ficiency in the lower limbs [1].
Chronic venous disease etiology has not been established
yet and in its development many factors are taken into con-
sideration, including genetic predisposition, lifestyle, physio-
logical characteristics, and some comorbidities or hormonal
therapy and contraception. Our study included obese patients
without signs of venous disease with a well-controlled blood
pressure. The factors used as exclusion criteria included those
that could potentially influence the observed biomechanical
parameters and blood viscosity. This allowed the creation of a
homogeneous group of patients, minimizing the impact of
hormonal factors and other pathologies associated with obe-
sity on the measured biomechanical parameters.
The results of our study showed that obesity is associated
with venous flow disturbances, which lead to changes of the
biomechanical forces on the venous wall. The femoral vein
Table 1 Baseline characteristics of obese patients and control
participants
Morbid obesityN=10 Control N=18 P value
Gender Male 4 (40 %) 4 (22.2 %) 0.369
Female 6 (60 %) 14 (77.8 %) 0.461
Age (years) 38.5 (33–40) 37 (27–40) 0.615
Weight (kg) 150.5 (126.5–160) 67 (62–73) <0.0001
BMI (kg/m2) 49.2 (44.1–52.9) 23.85 (22.45–24.65) <0.0001
WHR 1.09 (0.97–1.14) 0.8 (0.78–0.85) <0.0001
PeakV (cm/s) 17.53 (14.25–20.01) 24.92 (17.15–31.9) 0.044
TAmax (cm/s) 12.97 (11.51–14.6) 16.15 (13.2–21.7) 0.046
D (mm) 10.8 (10–11.4) 8.75 (8–9.2) <0.001
CSA (cm2) 0.91 (0.78–1.02) 0.6 (0.5–0.66) <0.001
Wall shear
stress (Pa)
0.21 (0.19–0.23) 0.31 (0.22–0.39) 0.032




4.38 (3.71–4.77) 3.88 (3.66–4.15) 0.041
Data are presented as the medians (interquartile ranges) for continuous
variables or the prevalences for categorical data. Group differences were
calculated using the unpaired Mann–Whitney U test for non-normal
distribution data and the Fisher’s exact test for categorical data
BMIbody mass index,WHRwaist to hip circumference ratio, PeakVpeak
velocity, TAmax time-averaged maximum velocity, D diameter, CSA cross-
sectional area of the vein
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diameter was significantly greater in obese participants com-
pared with nonobese participants. Venous hemodynamic
properties were lower in morbidly obese subjects. Lower
velocities and greater diameter resulted in lower shear rates
and wall shear stress. We have previously evaluated hemody-
namic parameters and hemorheological parameters, including
erythrocyte aggregation, among 35 obese patients qualified
for bariatric surgery [17]. This study has found that shear rate
and wall shear stress in obese subjects were lower than in the
nonobese. The results of our study confirm those of other
authors with regard to the same declining trend for shear stress
and venous hemodynamics [7].
These hemodynamic changes in morbidly obese individ-
uals are most likely related to the increased intra-abdominal
pressure caused by abdominal fat [18, 19]. Willenberg et al.
demonstrated that the application of external pressure to the
abdomen, simulating the effects of abdominal obesity, impacts
the venous flow and diameter of the femoral vein in a manner
similar to that observed in obese patients [20].
The results of this and other studies indicate that obesity
has a relevant impact on the biomechanical behavior of the
venous wall of the lower limbs. Our data show a significantly
lower value of shear stress at the femoral vein in morbidly
obese individuals compared to nonobese participants. Lower
shear stress might promote factors that support development
of venous pathologies, as was described by Bergan et al. [8].
The vascular endothelium is exposed to a spectrum of fluid
mechanical forces generated by blood flow; some of these,
such as fluid shear stress, can directly modulate endothelial
gene expression [21]. A previous study confirmed that wall
Table 2 Anthropometric parameters and venous hemodynamics of the lower limbs at each time point before and after surgery
Baseline N=10 6 months N=10 12 months N=10 P value
6 months vs. baseline 12 months vs. baseline
Weight (kg) 150.5 (126.5–160) 105.5 (102–126) 100 (97–108) 0.016 0.00034
BMI (kg/m2) 49.2 (44.1–52.9) 39.5 (34.2–40.7) 34.8 (31.3–37) 0.010 0.0001
WHR 1.09 (0.97–1.14) 0.95 (0.92–1.08) 0.9 (0.88–0.96) 0.127 0.0068
PeakV (cm/s) 17.53 (14.25–20.01) 17.14 (14.8–22.71) 25.1 (20.9–30.1) 0.979 0.040
TAmax (cm/s) 12.97 (11.51–14.6) 13.44 (11.18–16.21) 18.46 (13.24–24.13) 0.999 0.057
D (mm) 10.9 (10–11.4) 10 (8.8–11.5) 9.3 (8.2–9.8) 0.655 0.036
CSA (cm2) 0.9 (0.78–1.02) 0.79 (0.6–1.07) 0.68 (0.52–0.75) 0.702 0.039
Wall shear stress (Pa) 0.21 (0.19–0.23) 0.23 (0.21–0.32) 0.31 (0.23–0.52) 0.906 0.031
Shear rate (s−1) 47.92 (43.93–58.55) 54.4 (44.27–68.83) 76.81 (54.04–109.5) 0.907 0.020
Blood viscosity at 250 s−1 (mPa s) 4.38 (3.71–4.77) 4.62 (3.84–4.77) 4.62 (3.82–4.73) 0.952 0.952
Data are presented as median and interquartile range. Group differences were calculated by using the ANOVA test. For abbreviations, see Table 1
Fig. 1 Box plot comparing wall
shear stress at each time point
before and after surgery
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shear stress is an important determinant of endothelial cell
function [22]. Another study suggested that wall tension leads
to the expression of many proteins, including matrix metallo-
proteinase in the venous wall [23]. Laminar shear stress is
known to confer potent anti-inflammatory, antithrombotic,
and anti-adhesive effects by differentially regulating endothe-
lial gene expression [24–26].
The pathophysiology of venous disease depends on a con-
stellation of interrelated risk factors. Inflammation has recent-
ly been recognized as an important etiologic factor for venous
disease. Factors that influence the inflammatory process and
structural remodeling in venous valves and in the venous wall
remain unknown. On the other hand, it has been well docu-
mented that low shear stress and turbulent or reverse blood
flow lead to thrombosis and inflammatory reaction, which has
recently been recognized as an important etiologic factor for
venous disease [6, 27, 28]. This raises the question: Can the
weight loss due to bariatric surgery improve hemodynamic
and biomechanical conditions of the lower limbs in obese
patients? To our knowledge, the effects of weight loss due to
bariatric surgery on biomechanical behavior of the venous
wall of the lower limbs have not yet been established.
In this study, we observed a reduction in the diameter and
cross-sectional area of the vein and an increase in the PeakV
and maximal venous flow postoperatively after bariatric
weight loss surgery. The increasing trend was observed for
the biomechanical behavior of the venous wall of the lower
limbs at each time point after surgery. The wall shear stress
and the shear rate significantly increased 12 months after
surgery. The differences in the venous hemodynamics of the
lower limbs between the obese and control participants disap-
peared 1 year after surgery. The study was conducted in a
group of ten obese patients who underwent sleeve gastrecto-
my. Measurements of hemodynamic parameters were per-
formed before surgery and 6 and 12 months after surgery.
All patients were subjected to a prospective postoperative
control, according to a homogeneous, standardized research
model. The study group was small, but a thorough analysis of
the original data, presented in Figs. 1 and 2, clearly indicates
that in all obese patients 12 months after surgery, there was a
unidirectional increase in shear rate and wall shear stress.
Low shear stress promotes the migration of leukocytes,
coagulation and smooth cell proliferation, and induces chang-
es in endothelial cell function [6, 29, 30]. This effect of shear
stress on pathological alterations may lead to the preservation
and progression of venous dysfunction. Long-term adaptation
in obese subjects can involve structural and functional
remodeling of the venous wall. On the other hand, the
beneficial effects of weight loss due to sleeve gastrectomy on
the hemodynamics of blood flow and shear stress may cause
the opposite effect.
Fig. 2 Box plot comparing shear
rate at each time point before and
after surgery
Table 3 Differences in the venous hemodynamics of the lower limbs of
obese patients 12 months after surgery and control participants
12 months N=10 Control N=18 P value
PeakV (cm/s) 25.1 (20.9–30.1) 24.92 (17.15–31.9) 0.942
TAmax (cm/s) 18.46 (13.24–24.13) 16.15 (13.2–21.7) 0.648
D (mm) 9.3 (8.2–9.8) 8.75 (8–9.2) 0.130
CSA (cm2) 0.68 (0.52–0.75) 0.6 (0.5–0.66) 0.119
Wall shear
stress (Pa)
0.31 (0.23–0.52) 0.31 (0.22–0.39) 0.614
Shear rate (s−1) 76.81 (54.04–109.5) 76.89 (60.92–99.34) 0.980
Data are presented as the medians and interquartile ranges. Group differ-
ences were calculated using the unpaired Mann–Whitney U test. For
abbreviations, see Table 1
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The frequency of the occurrence of obesity in combination
with lower extremity venous disease indicates a multifactorial
relationship that, due to the excess weight, should also include
biomechanical factors. This study showed that weight loss due
to LSG significantly improves the biomechanical forces of the
femoral vein generated by blood flow. Obviously, it cannot be
concluded on the basis of the presented results that wall shear
stress changes after weight loss due to bariatric surgery influ-
ence the occurrence and progression of venous disease in the
obese. Further studies are needed to compare patients in
relation to the grade of venous insufficiency symptoms.
Study Limitations
The present manuscript was conceived as an initial prospec-
tive study assessing the effects of weight loss due to bariatric
surgery on biomechanical behavior of the venous wall in the
lower limbs. There are several limitations to the study that
need to be acknowledged. Its results cannot be extrapolated to
a general obese population because of the relatively small
number of patients. The findings with respect to long-term
biomechanical changes after bariatric surgery require larger
prospective studies to confirm our results. In addition, we did
not examine independent variables associated with postoper-
ative weight loss which can affect the hemodynamics of flow
and biomechanical behavior of the venous wall. The impact of
exercise and activity on changes of the biomechanical forces
on the venous wall before and after bariatric surgery might be
interesting. There are, however, obvious methodological dif-
ficulties in directly assessing the effect of increased activity
and exercise after surgery on biomechanical changes in the
venous wall. This exploration would require a homogenous
research model in which, in addition to surgery, there would
be implemented a uniform set of exercises.
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